Hepatocellular carcinoma CT: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(4 intermediate revisions by 2 users not shown)
Line 8: Line 8:


==CT scan==
==CT scan==
*[[Abdominal]] [[Computed tomography|CT scan]] may be helpful in the [[diagnosis]] of hepatocellular carcinoma (HCC). Findings on [[Computed tomography|CT scan]] suggestive of hepatocellular carcinoma include:<ref name="pmid18356450">{{cite journal |vauthors=Kim KW, Kim MJ, Lee SS, Kim HJ, Shin YM, Kim PN, Lee MG |title=Sparing of fatty infiltration around focal hepatic lesions in patients with hepatic steatosis: sonographic appearance with CT and MRI correlation |journal=AJR Am J Roentgenol |volume=190 |issue=4 |pages=1018–27 |year=2008 |pmid=18356450 |doi=10.2214/AJR.07.2863 |url=}}</ref><ref name="pmid25763723">{{cite journal |vauthors=Reynolds AR, Furlan A, Fetzer DT, Sasatomi E, Borhani AA, Heller MT, Tublin ME |title=Infiltrative hepatocellular carcinoma: what radiologists need to know |journal=Radiographics |volume=35 |issue=2 |pages=371–86 |year=2015 |pmid=25763723 |doi=10.1148/rg.352140114 |url=}}</ref><ref name="pmid27788724">{{cite journal |vauthors=Gao HQ, Hu CH, Yu YX, Hu S, Shi C, Wang XM, Guo L |title=[Value of spectral CT-based quantitative analysis in differential diagnosis of liver cancer and liver abscess] |language=Chinese |journal=Zhonghua Gan Zang Bing Za Zhi |volume=24 |issue=9 |pages=676–680 |year=2016 |pmid=27788724 |doi= |url=}}</ref>
*[[Abdominal]] [[Computed tomography|CT scan]] may be helpful in the [[diagnosis]] of hepatocellular carcinoma (HCC).  
*Findings on [[Computed tomography|CT scan]] suggestive of hepatocellular carcinoma include the following:<ref name="pmid18356450">{{cite journal |vauthors=Kim KW, Kim MJ, Lee SS, Kim HJ, Shin YM, Kim PN, Lee MG |title=Sparing of fatty infiltration around focal hepatic lesions in patients with hepatic steatosis: sonographic appearance with CT and MRI correlation |journal=AJR Am J Roentgenol |volume=190 |issue=4 |pages=1018–27 |year=2008 |pmid=18356450 |doi=10.2214/AJR.07.2863 |url=}}</ref><ref name="pmid25763723">{{cite journal |vauthors=Reynolds AR, Furlan A, Fetzer DT, Sasatomi E, Borhani AA, Heller MT, Tublin ME |title=Infiltrative hepatocellular carcinoma: what radiologists need to know |journal=Radiographics |volume=35 |issue=2 |pages=371–86 |year=2015 |pmid=25763723 |doi=10.1148/rg.352140114 |url=}}</ref><ref name="pmid27788724">{{cite journal |vauthors=Gao HQ, Hu CH, Yu YX, Hu S, Shi C, Wang XM, Guo L |title=[Value of spectral CT-based quantitative analysis in differential diagnosis of liver cancer and liver abscess] |language=Chinese |journal=Zhonghua Gan Zang Bing Za Zhi |volume=24 |issue=9 |pages=676–680 |year=2016 |pmid=27788724 |doi= |url=}}</ref><ref name="TerziSalvatore2015">{{cite journal|last1=Terzi|first1=Eleonora|last2=Salvatore|first2=Veronica|last3=Negrini|first3=Giulia|last4=Piscaglia|first4=Fabio|title=Ongoing challenges in the diagnosis of hepatocellular carcinoma|journal=Expert Review of Gastroenterology & Hepatology|volume=10|issue=4|year=2015|pages=451–463|issn=1747-4124|doi=10.1586/17474124.2016.1124758}}</ref>
**Enhanced mass during the arterial phase
**Enhanced mass during the arterial phase
**Wedge shaped [[perfusion]] abnormality because of the arterioportal shunts (APS)
**Wedge shaped [[perfusion]] abnormality because of the arterioportal shunts (APS)
Line 45: Line 46:
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Types of cancer]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Gastroenterology]]
[[Category:Radiology]]
[[Category:Surgery]]
[[Category:Surgery]]
[[Category:Emergency medicine]]

Latest revision as of 22:07, 29 July 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]

Hepatocellular carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes of Hepatocellular carcinoma

Differentiating Hepatocellular carcinoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic study of choice

History and symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatocellular carcinoma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatocellular carcinoma CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatocellular carcinoma CT

CDC on Hepatocellular carcinoma CT

Hepatocellular carcinoma CT in the news

Blogs on Hepatocellular carcinoma CT

Directions to Hospitals Treating Hepatocellular carcinoma

Risk calculators and risk factors for Hepatocellular carcinoma CT

Overview

Abdominal CT scan with intravenous contrast agent is used to diagnose hepatocellular carcinoma. Three-phase scanning (before contrast administration, immediately after contrast administration, and again after a delay) is employed to increase the ability of the radiologist to detect small tumors. It is important to optimize the parameters of the CT examination, because the underlying liver disease (e.g. hepatitis B) that most hepatocellular carcinoma patients have can make the findings more difficult to appreciate.

CT scan

  • Abdominal CT scan may be helpful in the diagnosis of hepatocellular carcinoma (HCC).
  • Findings on CT scan suggestive of hepatocellular carcinoma include the following:[1][2][3][4]
    • Enhanced mass during the arterial phase
    • Wedge shaped perfusion abnormality because of the arterioportal shunts (APS)
    • Focal fatty change in the normal liver
    • Focal fatty sparing in the diffusely fatty liver
    • Halo of focal fatty sparing around the hepatocellular carcinoma
Type Appearance
Massive HCC
  • Large hypoattenuating mass
  • May have necrosis/fat/calcification
Nodular HCC
  • Multiple masses of different attenuation are observed
  • Central necrosis may be observed
Infiltrative HCC
  • May be difficult to distinguish from associated cirrhosis

References

  1. Kim KW, Kim MJ, Lee SS, Kim HJ, Shin YM, Kim PN, Lee MG (2008). "Sparing of fatty infiltration around focal hepatic lesions in patients with hepatic steatosis: sonographic appearance with CT and MRI correlation". AJR Am J Roentgenol. 190 (4): 1018–27. doi:10.2214/AJR.07.2863. PMID 18356450.
  2. Reynolds AR, Furlan A, Fetzer DT, Sasatomi E, Borhani AA, Heller MT, Tublin ME (2015). "Infiltrative hepatocellular carcinoma: what radiologists need to know". Radiographics. 35 (2): 371–86. doi:10.1148/rg.352140114. PMID 25763723.
  3. Gao HQ, Hu CH, Yu YX, Hu S, Shi C, Wang XM, Guo L (2016). "[Value of spectral CT-based quantitative analysis in differential diagnosis of liver cancer and liver abscess]". Zhonghua Gan Zang Bing Za Zhi (in Chinese). 24 (9): 676–680. PMID 27788724.
  4. Terzi, Eleonora; Salvatore, Veronica; Negrini, Giulia; Piscaglia, Fabio (2015). "Ongoing challenges in the diagnosis of hepatocellular carcinoma". Expert Review of Gastroenterology & Hepatology. 10 (4): 451–463. doi:10.1586/17474124.2016.1124758. ISSN 1747-4124.
  5. "Hepatocellular carcinoma | Radiology Case | Radiopaedia.org".
  6. "Diffuse hepatocellular cancer with malignant portal vein thrombosis | Radiology Case | Radiopaedia.org".


Template:WikiDoc Sources